Zogenix Inc (ZGNX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Stephen J. Farr
Employees:
90
5858 HORTON STREET, #455, EMERYVILLE, CA 94608
(510) 550-8300

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Zogenix, Inc. is a pharmaceutical company, which engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. It develops two products candidate: ZX008 and Relday. The company was founded by Stephen J. Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.

Data derived from most recent annual or quarterly report
Market Cap 1.494 Billion Shares Outstanding55.992 Million Avg 30-day Volume 2.789 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-4.07
Price to Revenue11.1158 Debt to Equity0.9592 EBITDA-194.444 Million
Price to Book Value5.0737 Operating Margin-274.3261 Enterprise Value778 Million
Current Ratio3.629 EPS Growth-0.044 Quick Ratio3.192
1 Yr BETA 0.3268 52-week High/Low 26.9 / 11.03 Profit Margin-278.3854
Operating Cash Flow Growth-10.6094 Altman Z-Score-3.4226 Free Cash Flow to Firm -183.076 Million
View SEC Filings from ZGNX instead.

View recent insider trading info

Zogenix Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ZGNX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ZGNX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2022-03-09 by SMITH MICHAEL P
  • 4: filed on 2022-03-09 by BREITMEYER JAMES B
  • 4: filed on 2022-03-09 by STUTTS MARY E.
  • 4: filed on 2022-03-09 by WIGGINS MARK C
  • 4: filed on 2022-03-09 by BOCK LOUIS C
  • 4: filed on 2022-03-09 by TANNENBAUM RENEE P
  • 4: filed on 2022-03-09 by FARFEL GAIL M
  • 4: filed on 2022-03-09 by MAST ERLE T
  • 4: filed on 2022-03-09 by GALER BRADLEY S.
  • 4: filed on 2022-03-09 by LOEWY CAROLINE M

    • Events (8k)

  • 8-K: filed on 2022-03-07:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-24:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-01-19:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-02:
    Item 8.01: Other Events
  • 8-K: filed on 2021-11-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-09-28:
    Item 8.01: Other Events
  • 8-K: filed on 2021-08-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-06-02:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-05-06:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    GARNER CAM L

    • Director
    		 0 2022-03-07 0

    MAST ERLE T

    • Director
    		 0 2022-03-07 0

    WIGGINS MARK C

    • Director
    		 0 2022-03-07 0

    BREITMEYER JAMES B

    • Director
    		 0 2022-03-07 0

    FARR STEPHEN J PRESIDENT & CEO

    • Officer
    • Director
    		 0 2022-03-07 0

    BOCK LOUIS C

    • Director
    		 0 2022-03-07 0

    SMITH MICHAEL P EVP, CFO & TREASURER

    • Officer
    		 0 2022-03-07 0

    LOEWY CAROLINE M

    • Director
    		 0 2022-03-07 0

    TANNENBAUM RENEE P

    • Director
    		 0 2022-03-07 0

    GALER BRADLEY S. EVP & CHIEF MEDICAL OFFICER

    • Officer
    		 0 2022-03-07 0

    FARFEL GAIL M SEE REMARKS

    • Officer
    		 0 2022-03-07 0

    SAGROLIKAR ASHISH M EVP & CHIEF OPERATING OFFICER

    • Officer
    		 0 2022-03-07 0

    MITCHELL SHAWNTE EVP, GC & SECRETARY

    • Officer
    		 0 2022-03-07 0

    WAYNICK DENELLE J

    • Director
    		 0 2022-03-07 0

    STUTTS MARY E.

    • Director
    		 0 2022-03-07 0

    HAWLEY ROGER

    • Director
    		 10,575 2019-03-13 0

    PERCEPTIVE ADVISORS LLC

    PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

    EDELMAN JOSEPH

    • 10% Owner
    		 No longer subject to file 2018-08-10 0

    DARCIS THIERRY J.P. EVP / GENERAL MANAGER, EUROPE

    • Officer
    		 0 2017-03-14 0

    RHOADS ANN D EVP, CFO, TREASURER & SEC.

    • Officer
    		 0 2016-03-14 0

    SHIVELY RICHARD SCOTT CHIEF COMMERCIAL OFFICER

    • Officer
    		 358,771 2014-06-02 0

    BLAIR JAMES C

    • Director
    • 10% Owner
    		 0 2014-05-21 0

    ROBINSON CYNTHIA Y CHIEF DEVELOPMENT OFFICER

    • Officer
    		 0 2013-03-15 0

    WHEELER KURT

    • Director
    • 10% Owner
    		 0 2012-06-06 0

    MINOCHERHOMJEE ARDA PHD

    • Director
    		 0 2012-06-06 0

    SCALE VENTURE PARTNERS II, LP

    SCALE VENTURE MANAGEMENT II, LLC

    MITCHELL KATE

    O'DRISCOLL RORY

    WIENBAR SHARON L

    • FORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDER
    		 No longer subject to file 2011-09-21 0

    TREU JESSE I

    • 10% Owner
    		 10,092,586 2011-09-16 0

    CLARUS LIFESCIENCES I, L.P.

    CLARUS VENTURES I MANAGEMENT, L.P.

    CLARUS VENTURES I, LLC

    LIPTAK ROBERT

    SIMON NICHOLAS

    HENNER DENNIS

    GALAKATOS NICHOLAS

    WHEELER KURT

    STEINMETZ MICHAEL

    • Director
    • 10% Owner
    		 9,482,439 2011-09-16 0

    VITULLO NICOLE

    • 10% Owner
    		 10,092,586 2011-09-16 0

    DOVEY BRIAN H

    • 10% Owner
    		 10,092,586 2011-09-16 0

    SCHOEMAKER KATHLEEN K

    • 10% Owner
    		 10,092,586 2011-09-16 0

    HALAK BRIAN K

    • 10% Owner
    		 10,092,586 2011-09-16 0

    DP VII ASSOCIATES LP

    • 10% Owner
    		 169,251 2011-09-16 0

    DOMAIN PARTERS VII L P

    • 10% Owner
    		 9,923,335 2011-09-16 0

    KAMDAR KIM P.

    • 10% Owner
    		 11,000 2011-01-01 0

    CLARUS LIFESCIENCES I, L.P.

    CLARUS VENTURES I, LLC

    CLARUS VENTURES I MANAGEMENT, L.P.

    LIPTAK ROBERT

    SIMON NICHOLAS

    HENNER DENNIS

    GALAKATOS NICHOLAS

    STEINMETZ MICHAEL

    • 10% Owner
    		 5,982,439 2010-11-29 0

    THOMAS MCNERNEY & PARTNERS LP

    THOMAS, MCNERNEY & PARTNERS, LLC

    TMP NOMINEE, LLC

    TMP ASSOCIATES LP

    THOMAS, MCNERNEY & PARTNERS II L.P.

    THOMAS, MCNERNEY & PARTNERS II, LLC

    TMP NOMINEE II, LLC

    TMP ASSOCIATES II LP

    THOMAS JAMES E

    MCNERNEY PETE

    • SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)
    		 No longer subject to file 2010-11-29 0

    SCALE VENTURE PARTNERS II, LP

    SCALE VENTURE MANAGEMENT II, LLC

    BROOKS MARK J

    MITCHELL KATE

    O'DRISCOLL RORY

    WIENBAR SHARON L

    • 10% Owner
    		 9,124,993 2010-11-29 0

    DOMAIN PARTNERS VI, L.P.

    • 10% Owner
    		 9,894 2010-11-29 0

    DP VI ASSOCIATES, L.P.

    • 10% Owner
    		 106 2010-11-29 0

    CHICAGO GROWTH PARTNERS II L P

    CHICAGO GROWTH MANAGEMENT II, LLC

    CHICAGO GROWTH MANAGEMENT II, LP

    • SEE REMARKSSEE REMARKSSEE REMARKS
    		 No longer subject to file 2010-11-29 0

    HAAS KEN

    • Director
    		 2,335,218 2010-11-29 0

    DOMAIN ASSOCIATES

    • 10% Owner
    		 11,000 2010-11-22 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ZOGENIX INC ZGNX 2022-03-07 22:15:04 UTC -1.2258 1.2958 100000
    ZOGENIX INC ZGNX 2022-03-07 21:45:04 UTC -1.2258 1.2958 100000
    ZOGENIX INC ZGNX 2022-03-07 21:15:03 UTC -1.2258 1.2958 100000
    ZOGENIX INC ZGNX 2022-03-07 20:45:03 UTC -1.2258 1.2958 100000
    ZOGENIX INC ZGNX 2022-03-07 20:15:05 UTC -1.2258 1.2958 100000
    ZOGENIX INC ZGNX 2022-03-07 19:45:03 UTC -1.2258 1.2958 100000
    ZOGENIX INC ZGNX 2022-03-07 19:15:04 UTC -1.2258 1.2958 100000
    ZOGENIX INC ZGNX 2022-03-07 18:45:03 UTC -1.2258 1.2958 100000
    ZOGENIX INC ZGNX 2022-03-07 18:15:03 UTC -1.2258 1.2958 100000
    ZOGENIX INC ZGNX 2022-03-07 17:45:03 UTC -1.2258 1.2958 100000
    ZOGENIX INC ZGNX 2022-03-07 17:15:04 UTC -1.2258 1.2958 100000
    ZOGENIX INC ZGNX 2022-03-07 16:45:02 UTC -0.4075 0.4775 100000
    ZOGENIX INC ZGNX 2022-03-07 16:15:03 UTC -0.4075 0.4775 100000
    ZOGENIX INC ZGNX 2022-03-07 15:45:03 UTC -0.4075 0.4775 100000
    ZOGENIX INC ZGNX 2022-03-07 15:15:03 UTC -0.4075 0.4775 100000
    ZOGENIX INC ZGNX 2022-03-07 14:45:03 UTC -0.4075 0.4775 100000
    ZOGENIX INC ZGNX 2022-03-07 14:15:03 UTC -0.4075 0.4775 100000
    ZOGENIX INC ZGNX 2022-03-07 13:45:03 UTC -0.4075 0.4775 100000
    ZOGENIX INC ZGNX 2022-03-07 13:15:03 UTC -0.4075 0.4775 100000
    ZOGENIX INC ZGNX 2022-03-07 12:45:03 UTC -0.4075 0.4775 100000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    American Century Quantitative Equity Funds, Inc.- AC Alternatives Equity Market Neutral Fund ZGNX -2191.0 shares, $-114216.83 2019-12-31 N-PORT
    American Century Quantitative Equity Funds, Inc.- AC Alternatives Disciplined Long Short Fund ZGNX -1485.0 shares, $-77413.05 2019-12-31 N-PORT
    American Century Quantitative Equity Funds, Inc.- Core Equity Plus Fund ZGNX -7439.0 shares, $-297857.56 2019-09-30 N-PORT
    American Century Quantitative Equity Funds, Inc.- NT Core Equity Plus Fund ZGNX -23454.0 shares, $-939098.16 2019-09-30 N-PORT
    Trust for Professional Managers- Convergence Market Neutral Fund ZGNX -2797.0 shares, $-66204.99 2020-08-31 N-PORT
    FundVantage Trust- Gotham Defensive Long Fund ZGNX -26.0 shares, $-642.98 2020-03-31 N-PORT
    AQR Funds- AQR Small Cap Relaxed Constraint Equity Fund ZGNX -10.0 shares, $-400.4 2019-09-30 N-PORT
    FundVantage Trust- Gotham Index Plus All-Cap Fund ZGNX -41.0 shares, $-1013.93 2020-03-31 N-PORT
    INVESTMENT MANAGERS SERIES TRUST- AAM HIMCO Global Enhanced Dividend Fund ZGNX -4471.0 shares, $-87273.92 2021-03-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments